Afon Technology Limited’s (“Afon Technology”) board appoints Hyman Capital as advisor to its fund raising activities

The Board of Afon Technology has pleasure in announcing it is approaching the private funding market to raise £ 4 m to fund further miniaturisation of their medical device and manufacturing. The board has selected Hyman Capital to advise on this process.

Afon Technology has the single focus of commercialising a wearable, non-invasive blood glucose monitor to benefit people with diabetes the world over. Based on proven and patented technology, they have created a non-invasive, real-time and continuous glucose sensor that will empower people with diabetes in self-management and provide their clinicians with a history of their blood glucose variations. The compact device is designed to be worn with a watchstrap and connected via Bluetooth to the user’s smart watch/device. The device created gives individuals’ freedom from the constraints of conventional finger-stick devices.

Afon Technology is excited to report that they have appointed Hyman Capital as advisor to its fund-raising activities. Afon Technology is working with Hyman Capital, to identify potential investors to raise the £ 4 million.

Sabih Chaudhry, CEO of Afon Technology said, “We selected Hyman Capital because of their network of connections with appropriate investors and their understanding, experience and empathy for our company and development.”

Clive Hyman said, “We are glad to be working with Afon Technology, we have taken the time to understand the business and are working hand in glove with the management team to hone their materials.”

Enquiries welcomed

Clive Hyman, Hyman Capital +44 (0) 7388 245 446

Sabih Chaudhry, Afon Technology +44 (0) 7880 548 838

Notes to Editors

Notes on Company Name – www.afontechnology.com

Sabih Chaudhry, Afon Technology +44 (0)7880 548 838

Sabih Chaudhry is the Founder and CEO of Afon Technology Ltd., a start-up based in Chepstow, South Wales. He leads a world class team who are developing a wearable non-invasive blood glucose monitor. The technology is patented and has undergone a number of clinical trials at a diabetes test clinic in Germany. The technology is being designed to address both the diabetes and wearable markets, complying to all major global regulatory requirements.

Notes on Hyman Capital – www.hymancapital.com

Clive Hyman, Hyman Capital – +44 (0)7388 245 446

Clive Hyman is the Founder, Chair and CEO of Hyman Capital. He is a serial Chairman, non-executive, CEO and CFO with cash management, operational and M&A experience. He established the firm in 2005.

Established in 2005, Hyman Capital is a nimble boutique merchant bank, transaction services provider and business advisor.
We help young, growing businesses to access new sources of funding and to properly prepare for any transactions they are planning to undertake – while also advising them on becoming more efficient and effective.

These activities clearly go hand in hand, as helping a business to grow and become more profitable – either organically or through acquisition – can only ever help it become a more attractive investment possibility.


Attached Media


Press Contacts